Cerebellar ataxia and central nervous system whipple disease

Archives of Neurology

Volumn 62, Issue 4, 2005, Pages 618-620

  Matthews, Brandy R ^a   Jones, Lyell K ^a   Saad, Dahlia A ^a   Aksamit, Allen J ^a   Josephs, Keith A ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; COTRIMOXAZOLE;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; INTESTINE LIPODYSTROPHY; MALE; MUSCLE DISEASE; OCULOMASTICATORY MYORRHYTHMIA; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADULT; AGE OF ONSET; AGED; CEFTRIAXONE; CEREBELLAR ATAXIA; CEREBELLUM; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MINNESOTA; PREVALENCE; SULFAMETHOXAZOLE; TREATMENT OUTCOME; TRIMETHOPRIM; WHIPPLE DISEASE;

EID: 16844367260     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.4.618     Document Type: Article

References (17)

1. Whipple GH. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Johns Hopkins Hosp Bull. 1907;18:382-391.
2. Chears WC, Ashworth CT. Electron microscopic study of the intestinal mucosa in Whipple's disease: demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology. 1961;41:129-138.
3. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med. 1992;327:293-301.
4. Maiwald M, Relman DA. Whipple's disease and Tropheryma whippelii: secrets slowly revealed. Clin Infect Dis. 2001;32:457-463.
5. Louis ED, Lynch T, Kauffman P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol. 1996;40:561-568.
6. Skeen MB. Neurologic manifestations of gastrointestinal disease. Neurol Clin. 2002;20:195-225.
7. Gerard A, Sarrot-Reynauld F, Liozon E, et al. Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine. 2002;81:443-457.
8. Schmahmann JD. Whipple disease of the nervous system. In: Noseworthy J, ed. Neurological Therapeutics: Principles and Practice. London, England: Martin Dunitz; 2003;1499-1501.
9. Dobbins WO III. Whipple's disease. Mayo Clin Proc. 1988;63:623-624.
10. Brown AP, Lane JC, Murayama S, Vollmer DG. Whipple's disease presenting with isolated neurological symptoms. J Neurosurg. 1990;73:623-627.
11. Flemmer M, Esterowitz T. Detecting Whipple's disease: man versus machine. Am J Gastroenterol. 2002;97:2675-2676.
12. Dobbins WO III, ed. Whipple's Disease. Springfield, III: Charles C Thomas Publisher: 1987.
13. Uldry PA, Bogousslavsky J. Partially reversible parkinsonism in Whipple's disease with antibiotherapy. Eur Neurol. 1992;32:151-153.
14. Bajaj NP, Lees A, Giovannoni G, Bhatia K, Quinn N. Movement disorders in Whipple's disease [abstract]. Neurology. 2001(suppl 3):A119.
15. Schwartz MA, Selhorst JB, Ochs AL, et al. Oculomasticatory myorrhythmia: a unique movement disorder occurring in Whipple's disease. Ann Neurol. 1986;20:677-683.
16. Van Bogaert L, Lafon R, Pages P, Labauge R. Sur une encephalite subaigue non classable, principablement caracterisee par des myorythmies oculo-facio-cervicales. Rev Neurol (Paris). 1963;109:443-453.
17. Fleming JL, Wiesner RH, Shorter RG. Whipple's disease: clinical, biochemical, and histopathological features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63:539-551.